X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
SUVEN LIFE Fact Sheet, SUVEN LIFE Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE Fact Sheet   (SVNP)

Here is the latest financial fact sheet of SUVEN LIFE. For more details, see the SUVEN LIFE quarterly results and SUVEN LIFE share price and chart. For a sector overview, read our pharmaceuticals sector report.

SUVEN LIFE Price History

Price Rs 223.8
Mkt Cap Rs m 26,141
Vol '000 46.4
P/E X 16.5
P/CF X 24.1
EPS (TTM) Rs 13.6
% ch % 3.3
No. of shares m 116.83
% ch week % 3.0
% ch 1-mth % 0.0
% ch 12-mth % 30.9
52 week H/L Rs 250.8/155.0
(As on Jul 20, 2018 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

SUVEN LIFE Financials

No. of Mths
Year Ending
12
Mar-13
12
Mar-14
12
Mar-15
12
Mar-16
12
Mar-17
5-Yr Chart
Click to enlarge
SUVEN LIFE EQUITY SHARE DATA
High Rs3583323339229 
Low Rs142272144151 
Sales per share (Unadj.) Rs22.143.740.939.242.7 
Earnings per share (Unadj.) Rs2.612.38.55.66.9 
Diluted earnings per shareRs2.612.39.36.17.5 
Cash flow per share (Unadj.) Rs3.313.19.57.08.5 
Dividends per share (Unadj.) Rs0.300.500.602.001.00 
Adj. dividends per shareRs0.300.500.652.181.09 
Dividend yield (eoy) %1.20.90.30.80.5 
Book value per share (Unadj.) Rs13.222.644.346.852.4 
Adj. book value per shareRs13.222.648.251.057.1 
Shares outstanding (eoy) m116.82116.82127.28127.28127.28 
Bonus/Rights/Conversions  OI-IS-- 
Price / Sales ratio x1.11.24.86.24.4 
Avg P/E ratio x9.24.323.142.827.7 
P/CF ratio (eoy) x7.44.020.834.422.2 
Price / Book Value ratio x1.82.34.55.23.6 
Dividend payout %11.44.17.035.414.6 
Avg Mkt Cap Rs m2,8506,15625,10030,73224,158 
No. of employees `000NANA0.91.01.0 
Total wages/salary Rs m254314365409522 
Avg. sales/employee Rs ThNMNM5,912.15,236.15,349.7 
Avg. wages/employee Rs ThNMNM414.4429.1513.5 
Avg. net profit/employee Rs ThNMNM1,234.4753.0858.1 
SUVEN LIFE INCOME DATA
Net Sales Rs m2,5795,1035,2094,9955,435 
Other income Rs m103086194211 
Total revenues Rs m2,5895,1335,2945,1895,646 
Gross profit Rs m5322,1911,5951,0161,291 
Depreciation Rs m7988118175214 
Interest Rs m135105475957 
Profit before tax Rs m3292,0271,5169761,231 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m20586428257359 
Profit after tax Rs m3081,4421,088718872 
Gross profit margin %20.642.930.620.323.7 
Effective tax rate %6.128.928.226.429.2 
Net profit margin %12.028.220.914.416.0 
SUVEN LIFE BALANCE SHEET DATA
Current assets Rs m1,3692,8064,4944,2774,917 
Current liabilities Rs m1,0741,5511,1851,1071,186 
Net working cap to sales %11.424.663.563.568.6 
Current ratio x1.31.83.83.94.1 
Inventory Days Days7656576162 
Debtors Days Days3447283931 
Net fixed assets Rs m1,6571,9212,7903,1263,154 
Share capital Rs m117117127127127 
"Free" reserves Rs m1,0262,1255,5105,8266,543 
Net worth Rs m1,5452,6455,6375,9536,670 
Long term debt Rs m642377594416259 
Total assets Rs m3,2764,8667,4567,5158,157 
Interest coverage x3.420.333.217.622.7 
Debt to equity ratio x0.40.10.10.10 
Sales to assets ratio x0.81.00.70.70.7 
Return on assets %13.531.815.210.311.4 
Return on equity %20.054.519.312.113.1 
Return on capital %21.270.625.116.218.6 
Exports to sales %84.590.188.187.50 
Imports to sales %15.19.411.612.20 
Exports (fob) Rs m2,1804,6004,5904,3710 
Imports (cif) Rs m3894826026110 
Fx inflow Rs m2,1804,7524,7794,6664,996 
Fx outflow Rs m515608855942959 
Net fx Rs m1,6654,1433,9243,7244,037 
SUVEN LIFE CASH FLOW
From Operations Rs m 307 1,212 1,429 675 1,088 
From Investments Rs m -147 -355 -1,105 -386 -3,107 
From Financial Activity Rs m 26 -382 1,791 -681 -300 
Net Cashflow Rs m 186 474 2,116 -392 -2,319 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 63.4%
Foreign collaborators 0.0%
Indian inst/Mut Fund 0.0%
FIIs 0.0%
ADR/GDR 0.0%
Free float 36.5%
Shareholders 37,287
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF SDE Serene Chambers, Road No.5, Avenue 7, Banjara Hills, Hyderabad - 500 034
E-MAIL investorservices@suven.com WEB www.suven.com
TELEPHONE (040) 2354 3311 FAX (040) 2354 1152
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Karvy Computershare, 17-24, Vithalrao Nagar, Madhapur, Hyderabad-81
AUDITOR Karvy & Company
COMP SEC: K. Hanumantha Rao YEAR OF INC: 1989 BSE CODE: 530239 FV (Rs): 1 DIV YIELD (%): 0.5

More Pharmaceuticals Company Fact Sheets:   PLETHICO PHARMA  ORCHID PHARMA LTD  GLENMARK PHARMA  SUN PHARMA  NOVARTIS  

Compare SUVEN LIFE With:   PLETHICO PHARMA  ORCHID PHARMA LTD  GLENMARK PHARMA  SUN PHARMA  NOVARTIS  

Compare SUVEN LIFE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Of IPOs, LIC-IDBI Bank Deal, and Top Cues in Focus Today(Pre-Open)

Share markets in India closed marginally higher on Friday last week. All sectoral indices traded in green, with stocks in the IT sector and stocks in the pharma sector, leading the gains.

Views on news

SUVEN LIFE Announces Quarterly Results (4QFY18); Net Profit Up 56.0% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, SUVEN LIFE has posted a net profit of Rs 625 m (up 56.0% YoY). Sales on the other hand came in at Rs 2 bn (up 18.6% YoY). Read on for a complete analysis of SUVEN LIFE's quarterly results.

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

Sintex's Auditor Resigns. How You Can Protect Yourself from Such Stocks(The 5 Minute Wrapup)

Jul 20, 2018

While the attack on the bad corporate governance is an overhang in the near term...this can be a game-changer in the years to come.

The Answer to Your Wealth Worries: Small Caps (Especially Now)(Profit Hunter)

Jul 10, 2018

If you're worried about the markets - you are on the wrong track. This is opportunity - put your wealth-building hat on, instead - Richa shows you how...

The Multiple Problems with the Minimum Support Price (MSP) System(Vivek Kaul's Diary)

Jul 11, 2018

The price signals that MSP sends out, creates its own set of problems.

PPF v/s Mutual Funds: Which Is Better?(Outside View)

Jul 10, 2018

PersonalFN highlights the key points of distinction between PPF and mutual funds.

ICICI Pru Mutual Fund Tarakki Karega! - The Unethical Way?(Outside View)

Jul 11, 2018

PersonalFN explains how ICICI Prudential Mutual Fund flouted the norms of related party transactions while subscribing to the IPO of ICICI Securities.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN LIFE

SUVEN LIFE - IPCA LABS COMPARISON

COMPARE SUVEN LIFE WITH

MARKET STATS